We are live on ! Find out more
CK

Cohen Klingenstein Portfolio holdings

AUM $3.49B
1-Year Est. Return 26.65%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.7%
5 Year Est. Return
+104.29%
10 Year Est. Return
+422.19%
AUM
$1.72B
AUM Growth
+$131M
Cap. Flow
-$5.02M
Cap. Flow %
-0.29%
Top 10 Hldgs %
41.32%
Holding
241
New
2
Increased
10
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.87M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$702K
3
PFE icon
Pfizer
PFE
+$514K
4
CSCO icon
Cisco
CSCO
+$502K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$228K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.98M
2
AMZN icon
Amazon
AMZN
+$2.34M
3
DIS icon
Walt Disney
DIS
+$988K
4
PEP icon
PepsiCo
PEP
+$606K
5
AABA
Altaba Inc
AABA
+$516K

Sector Composition

Rank Sector Weight
1 Communication Services 15.62%
2 Financials 11.66%
3 Industrials 11.04%
4 Healthcare 10.8%
5 Technology 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$933B
$15.9M 0.93%
114,279
– –
PYPL icon
27
PayPal
PYPL
$49.3B
$15.9M 0.92%
147,117
– –
ITW icon
28
Illinois Tool Works
ITW
$81.6B
$15.1M 0.88%
84,200
– –
HIG icon
29
Hartford Financial Services
HIG
$39.2B
$15M 0.87%
246,500
– –
MDT icon
30
Medtronic
MDT
$110B
$14.2M 0.82%
124,827
– –
CL icon
31
Colgate-Palmolive
CL
$73.3B
$14.1M 0.82%
205,200
– –
AVGO icon
32
Broadcom
AVGO
$1.85T
$13.6M 0.79%
430,700
– –
ADBE icon
33
Adobe
ADBE
$98.5B
$12.8M 0.74%
38,658
– –
GSK icon
34
GSK
GSK
$104B
$12.6M 0.73%
214,984
– –
RTX icon
35
RTX Corp
RTX
$289B
$12.5M 0.73%
132,853
– –
TMO icon
36
Thermo Fisher Scientific
TMO
$214B
$11.8M 0.68%
36,251
– –
BAC icon
37
Bank of America
BAC
$433B
$10.8M 0.63%
305,817
+152
+0% +$4.91K
MMM icon
38
3M
MMM
$90.8B
$10.3M 0.6%
69,607
– –
T icon
39
AT&T
T
$159B
$10.2M 0.59%
345,110
– –
AL
40
DELISTED
Air Lease Corp
AL
$10.1M 0.59%
213,139
– –
CCI icon
41
Crown Castle
CCI
$33.4B
$9.91M 0.58%
69,737
– –
HES
42
DELISTED
Hess
HES
$9.73M 0.57%
145,600
– –
PANW icon
43
Palo Alto Networks
PANW
$265B
$9M 0.52%
233,622
– –
SAP icon
44
SAP
SAP
$209B
$8.68M 0.5%
64,755
– –
C icon
45
Citigroup
C
$222B
$8.58M 0.5%
107,451
– –
FDX icon
46
FedEx
FDX
$73B
$8.58M 0.5%
56,714
– –
NSC icon
47
Norfolk Southern
NSC
$75B
$8.55M 0.5%
44,050
– –
VMC icon
48
Vulcan Materials
VMC
$35.1B
$8.5M 0.49%
59,058
– –
YUMC icon
49
Yum China
YUMC
$15.9B
$7.97M 0.46%
166,100
– –
AMGN icon
50
Amgen
AMGN
$209B
$7.96M 0.46%
33,020
– –
1
2
3 4 5

Similar funds

DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Cohen Klingenstein's Q4 2019 Portfolio in Review

As of Q4 2019, Cohen Klingenstein held 241 positions worth $1.72B, up 8.2% from $1.59B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 1.7%. Cohen Klingenstein opened 2 new positions and exited 2, leaving the 241-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

  • Cohen Klingenstein's largest Q4 2019 buy was iShares Core S&P Small-Cap ETF: 2,400 shares worth $201K.
  • Cohen Klingenstein added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.87M increase.
  • Cohen Klingenstein's biggest Q4 2019 reduction was Amazon, cutting an estimated $2.34M.
  • Cohen Klingenstein fully exited Celgene Corp in Q4 2019, selling an estimated $4.98M.
  • Cohen Klingenstein's ten largest holdings make up 41% of its $1.72B portfolio in Q4 2019.
  • Cohen Klingenstein opened 2 new positions and closed 2 in Q4 2019.
  • Cohen Klingenstein's portfolio value rose 8.2% quarter-over-quarter to $1.72B.

Based on Cohen Klingenstein's 13F filing for Q4 2019, filed 15 Jan 2020.